UiPath (NYSE:PATH) Stock Price Down 1.1% After Insider Selling

UiPath, Inc. (NYSE:PATH) fell 1.1% during trading on Tuesday after an insider sold shares in the company. The company traded as low as $16.63 and last traded at $16.6690. 21,407,926 shares changed hands during mid-day trading, an increase of 35% from the average session volume of 15,805,548 shares. The stock had previously closed at $16.85.

Specifically, CEO Daniel Dines sold 45,000 shares of the business’s stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $16.44, for a total value of $739,800.00. Following the sale, the chief executive officer directly owned 28,568,585 shares in the company, valued at approximately $469,667,537.40. The trade was a 0.16% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Daniel Dines sold 45,000 shares of the firm’s stock in a transaction on Friday, December 26th. The stock was sold at an average price of $16.90, for a total value of $760,500.00. Following the transaction, the chief executive officer owned 28,613,585 shares of the company’s stock, valued at approximately $483,569,586.50. This represents a 0.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In related news, CEO Daniel Dines sold 45,000 shares of UiPath stock in a transaction that occurred on Wednesday, December 24th. The shares were sold at an average price of $16.91, for a total value of $760,950.00. Following the completion of the transaction, the chief executive officer owned 28,658,585 shares in the company, valued at approximately $484,616,672.35. The trade was a 0.16% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on PATH. Needham & Company LLC reissued a “hold” rating on shares of UiPath in a research report on Thursday, December 4th. Royal Bank Of Canada lifted their price target on UiPath from $16.00 to $19.00 and gave the stock a “sector perform” rating in a research report on Wednesday, December 10th. Mizuho upped their target price on shares of UiPath from $14.00 to $15.00 and gave the company a “neutral” rating in a report on Thursday, December 4th. Canaccord Genuity Group lifted their price objective on shares of UiPath from $15.00 to $19.00 and gave the company a “buy” rating in a research report on Thursday, December 4th. Finally, Evercore ISI boosted their target price on UiPath from $15.00 to $17.00 and gave the stock an “in-line” rating in a research report on Thursday, December 4th. One investment analyst has rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $16.00.

UiPath News Roundup

Here are the key news stories impacting UiPath this week:

• Positive Sentiment: Morgan Stanley raised its price target on UiPath after the company reported a strong FQ3 beat and reached a profitability milestone — a catalyst that supports upside vs. the prior consensus. Morgan Stanley Upgrades UiPath
• Positive Sentiment: Zacks highlights UiPath’s AI-driven automation momentum, enterprise adoption and strong cash position as advantages versus peers — a constructive framing for investors focused on software quality and balance-sheet resiliency. MVST vs. PATH: Which Growth Tech Stock Belongs in Your Portfolio?
• Positive Sentiment: UiPath is listed among notable AI agent platforms in Forbes, reinforcing its positioning in the AI automation narrative that can support longer-term revenue expansion and multiple re-rating potential. 10 AI Agent Platforms Every Business Leader Needs To Know
• Neutral Sentiment: Market commentary and trending-stock writeups (Zacks, MarketBeat) show heightened investor attention and varied analyst ratings (consensus “Hold” and mixed price targets), suggesting divergence in near-term expectations. UiPath Is a Trending Stock: Facts to Know
• Neutral Sentiment: Media told investors to “mark your calendars for January 2” — indicating an upcoming date (market/event window) that could drive short-term movement, but details on the specific catalyst were not definitive in the headline. Dear UiPath stock fans, mark your calendars for January 2
• Negative Sentiment: CEO Daniel Dines has been selling multiple 45,000-share blocks across December (recent filings show continued disposals). Repeated insider selling can weigh on sentiment and may pressure the stock until buyers absorb the supply. SEC filing: Insider sales by Daniel Dines

UiPath Price Performance

The stock has a market capitalization of $8.91 billion, a P/E ratio of 39.69, a PEG ratio of 5.09 and a beta of 1.10. The stock’s 50-day simple moving average is $15.54 and its 200 day simple moving average is $13.55.

UiPath (NYSE:PATH) last issued its quarterly earnings data on Wednesday, December 3rd. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.02. The firm had revenue of $411.11 million during the quarter, compared to the consensus estimate of $392.46 million. UiPath had a net margin of 14.79% and a return on equity of 3.73%. The business’s revenue for the quarter was up 15.9% compared to the same quarter last year. During the same period last year, the business posted $0.11 earnings per share. As a group, analysts expect that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.

Institutional Trading of UiPath

Several hedge funds and other institutional investors have recently bought and sold shares of PATH. Twin Peaks Wealth Advisors LLC acquired a new position in UiPath in the 2nd quarter valued at $28,000. AdvisorNet Financial Inc grew its holdings in shares of UiPath by 320.4% during the 2nd quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company’s stock valued at $32,000 after purchasing an additional 1,887 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of UiPath by 48.0% during the second quarter. GAMMA Investing LLC now owns 2,989 shares of the company’s stock worth $38,000 after buying an additional 969 shares in the last quarter. IFP Advisors Inc raised its position in UiPath by 508.0% in the second quarter. IFP Advisors Inc now owns 3,283 shares of the company’s stock valued at $42,000 after purchasing an additional 2,743 shares during the last quarter. Finally, Bayforest Capital Ltd raised its holdings in UiPath by 852.4% in the 2nd quarter. Bayforest Capital Ltd now owns 4,143 shares of the company’s stock valued at $53,000 after buying an additional 3,708 shares during the last quarter. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.